| |
|
|
Rimonabant Disclamer
Disclamer
The Buy-Rimonabant.com website purpose
is to present information about Rimonabant (generic
Acomplia) medication (collected from reliable sources)
that have been approved by the appropriate medical and governing
authorities in the USA and Europe. However, the health and
medical information published on the Buy-Rimonabant.com
should not be considered as a medical advice to any degree
and/or an effort to swap any discussions with an health
care professional that will be tailored to individual specifications.
We do not give any medical advice or any clinical treatment
information. We recommend you to contact your health care
professional if you need any medical information or advice.
We do not respond to any specific medical queries.
Copyright
All material/content or information on Buy-Rimonabant.com
is subject to modification at anytime, without any prior
notice. The content/information/graphics/designs/compilation
and other matters related to this website are Buy-Rimonabant.com
property. Our country is a member of the Berne Convention
and Universal Copyright Convention (UCC), which allows us
to protect our works worldwide. If we, at any moment, detect
a violation of our copyright by another individual or entity,
we are entitled to assert a claim.
ALL TRADEMARKS WHETHER MARKED OR UNMARKED,
ARE THE PROPERTY OF THEIR RESPECTIVE OWNERS.
|
|
|
|
Brief:
•
Acomplia is the brand name of a new prescription
weight loss drug for dieters, Rimonabant, that has
recently (June 28th, 2006) been approved for use
by patients in the UK.
•
Acomplia also reduces the desire for nicotine, but
is not yet licensed as an aid to stopping smoking.
•
Acomplia is licensed within the European Union,
but has yet to be approved by the FDA in the US.
•
Acomplia is manufactured by the pharmaceutical company
Sanofi Aventis. Its generic name is Rimonabant.
|
|
|
